P/E adj.
Net profit (adj.)
P/B
Book value
P/FCF
FCF
Yield
Growth potential
Teva Pharmaceutical Industries news
03.05.2022
Teva Pharmaceutical Industries' GAAP loss for 3 months of 2022 was $952 million, against a profit of $84 million in the previous year. Revenues decreased by 8.1% to $3.661 billion from $3.982 billion the year before.
Source: 
ir.tevapharm.com
ir.tevapharm.com
09.02.2022
Teva Pharmaceutical Industries' GAAP net income for 2021 was $0.456 billion, compared with a loss of $4.099 billion in the previous year. Revenues decreased by 4.7% to $15.878 billion from $16.659 billion the year before.
Source: ir.tevapharm.com
ir.tevapharm.com
27.10.2021
Teva Pharmaceutical Industries' GAAP net profit for 9M 2021 amounted to $0.608 bln, against a loss of $4.261 bln in the previous year. Revenues fell 3.5% to $11.778 billion from $12.206 billion a year earlier.
Source: ir.tevapharm.com
ir.tevapharm.com
28.07.2021
Teva Pharmaceutical Industries net profit according to GAAP for 6 months of 2021 amounted to $306 million, increasing 3.9 times compared to $78 million in the previous year. Revenues decreased 4.1% to $7.892 billion from $8.227 billion a year earlier.
Source: ir.tevapharm.com
ir.tevapharm.com
General information
| Company name | Teva Pharmaceutical Industries |
|---|---|
| Tags | #pharmacy |
| Sector | Health Care / Pharmaceuticals, Biotechnology & Life Sciences / Pharmaceuticals / Pharmaceuticals |
| Business address | 5 BAZEL ST P O B 3190 PETACH TIKVA L3 49131 9729267267 |
| Mailing address | TEVA PHARMACEUTICAL INDUSTRIES LIMITED 5 BAZEL ST PO B 3190 PETACH TIKVA L3 49131 |
| Website | www.tevapharm.com |
| Information disclosure | www.sec.gov |
English (US) 